rheumatic disease Flashcards

1
Q

rheumatic diseases

A

localized or systemic inflammation
- msk system damage, internal organ damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

endogenous vs exogenous in initiating forces of acute diseases

A

edo: crystal deposition, uric acid (gout)
exo: new medication of infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

general principels of rheumatic diseases

A

disease initiation, propagation, flares

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

chronic disease initiating force

A

remote and unrecognizable (no longer present with typical acute inflammation symptoms)
disease phenotype is fully established

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

propagation of rheumatic disease

A

autoimmune response- self-amplified cycle of damage, self-antigens, can elicit innate and adaptive immune response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

self-limited

A

acute episodes of RD. removal of stimulus that causes the inflammation, re-exposure can cause flares

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

pathogenesis of inflammation 1) cytokines

A

upregulation of cytokines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

2) endothelial activation

A

pro-inflammatory cytokines-> promote inflammation-> trigger adhesion-promoting receptors on blood vessel endothelium (Adhesion!)
contributes to atherosclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

3) complement pathway

A

augments, amplifies the inflammatory response.
or upregulation= abnormal response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

4) immune complex formation

A

macrophages and neutrophil complexes- damage healthy tissue if released in large amounts- follows upregulation of complement pathway
might present as a rash

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

5a) cellular cytotoxicity upregulation

A

cell mediated: cytotoxic T lymphocytes - capable of destroying target cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

5b) cellular cytotoxicity upregulation

A

antibody-dependent cellular cytotoxicity: destruction of antibody-coated target cells by natural killer cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

6) host tissue differentiation

A

inflammatory mediators and t cells stimulate cells unrelated to immune response to change function. (think metaplasia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

gout clinical presentation

A

crystal-induced inflammation of synovial joints
male 3x more than female
monosodium urate crystals in joint space= sever acute joint pain and swelling
most common locations: great toe, midfoot, ankle and knee

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

gout flare ups

A

flares: one week, typically resolve spontaneously (self-limiting)
overtime flares can become more frequent and painful- results in chronic destructive condition (joint deformity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

underexcretion vs overproduction etiology in gout

A

under: 90% of patients, most often due to impaired renal function or diuretics
over: 10% of patiens diet, medication, defects in pathway leading to increased uric acid production

17
Q

immune system mechanisms involved in gout

A

triggers complement pathway- attracts neutrophils
vasodilators- pain and swelling
macrophage destruction of crytsals- increased adhesion molecules and localized endothelium response

18
Q

gout clinical manifestations

A

podagra: sever inflammatory arthritis at the first metatarsal joint- most frequent
d/dx episodic oligoarticular arthritis: most common type of juvenile arthritis
tophi formation: chronic gout most often occurs on tendon tissue on extensor side of hand
chronic erosive polyarthritis: over years, destruction of joints

19
Q

gout treatment

A

anti-inflammatory medication, activation of involved joints- AROM/PROM
prevention: decrease serum uric acid levels (diet)

20
Q

immune complex vasculitis clinical presentation

A

acute inflammatory disease of the small blood vessels, palpable purpura, arthritis, abdominal pain

21
Q

etiology of immune complex vasulitis

A

antigen from exogenous source- skin infection, virus, seasonal allergies
antigen from endogenous source- systemic lupus, vascular immunoglobins (proteins)
both result in intense inflammatory response

22
Q

pathophysiology of ICV

A

antigens elicit an ongoing humoral response due to abundant quantities- initiators
deposition of immune complexes in vessel endothelium- propagator
typically self limiting

23
Q

serum sickness

A

immune system reacts to medicines that contain proteins used to treat immune conditions

24
Q

clinical presentation of lupus

A

systemic autoimmune RD- chronic inflammation injury damage to multiple organs
females 9x more than men

25
lupus etiology
complex- genetic susceptibility and poorly defines environmental factors inefficient clearance of nonimmune apoptotic cells- upregulation inflammatory response
26
initiation of lupus
hyperactive autoantibody response to self-antigens (comp pathway) unique apoptotic cell death stimulates immune response
27
propagation of lupus
combined result- continued immune response and tissue damage due to response derived from apoptotic cells and damaged cells auto-amplification: hallmark of lupus
28
clinical manifestation of lupus
multisystem autoimmune disease, characterized by periodic flares, symptoms are highly varied, universal feature: production of autoantibodies, skin rash, renal disease, hematologic disturbances, inflammation of serosal surfaces, neurologic syndromes.
29
clincial presentation of rheumatoid arthritis
chronic systemic inflam disease persistent symmetric inflammattion of multple peripheral joints characterized by chronic inflam proliferation of synovial lining of diarthrodial joints- aggressive cartilage destruction adn bony erosion **
30
epidemiology of rheumatoid arthritis
1% of pop femal 3x more onset in 60s
31
etiology of RA
majority of destruction occurs in joint rynovium- lungs, skin and blood vessels can be affected genetic and environmnetal factors can influence condition
32
pathophysiology of RA
synovium significantly expansion of cellular lining composed of activated cells, high concentration of b cells, t cells, macrophahes= joint pannus RA synovium can invade adjacent tissue such as cartlage and bone decreased ROM
33
initiaitino of RA
genetic factor environmental factor: cigarette smoking autoantibodies: hallmark featur- development of antigen-driven autoantibodies
34
RA propogation
autoantigen interact with immune cells- amplify disease process
35
RA clinical manifestation
persistent progressive disease, fatigue and joint inflammation, small and large joints (bilateral) joint deformities, cervical spine can be involved but not lower spine
36
RA treatment
anti-inflammatories, immunomodulatory all aim to slow progressive joint erosion
37